SLGCW
SomaLogic IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.53
Beta
1.64
52W High
$0.00
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-159.50%
Forward P/E
—
PEG Ratio
—
About SomaLogic Inc
SomaLogic Inc. is a pioneering life sciences company specializing in proteomics, the study of proteins and their functions. Leveraging its proprietary SomaSignal technology, SomaLogic enables precise and predictive health assessments through extensive biomarker discovery and analysis. The company's innovative platform has broad applications across diagnostics, therapeutics, and personalized medicine, providing valuable insights for both healthcare providers and patients. With a robust pipeline of products and partnerships aimed at improving health outcomes, SomaLogic is positioned to play a critical role in advancing modern healthcare and transforming how diseases are understood and treated.
Fundamentals
| Revenue (TTM) | $81.72M |
| Gross Profit (TTM) | 0 |
| EBITDA | $-134.86M |
| Operating Margin | -108.50% |
| Return on Equity | -23.70% |
| Return on Assets | -14.20% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $2.63 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -47.10% |
| Shares Outstanding | 0 |
| Float | $153.26M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/16/2026